MedTrace Logo

Nutritional Status in Patients With Chronic Kidney Disease

NCT06580093 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2025-09-26

No results posted yet for this study

Summary

The goal of this observational study is to investigate how the GLIM criteria\* for the diagnosis of malnutrition should be operationalized in patients with chronic kidney disease (CKD) treated with hemodialysis. The main questions it aims to answer are:

* How can malnutrition be defined when applying different combinations and operationalization strategies of the GLIM criteria?
* How can information from other nutrition assessment tools be used in the operationalization of GLIM?
* Which combinations and operationalization strategies of the GLIM criteria can best predict deterioration in quality of life, muscle strength, and increased mortality? An observational study on patients with CKD in hemodialysis will be performed. Variables will be extracted from the Swedish renal registry, SNR and medical records at two hemodialysis units at one university hospital in Sweden. With start in the fall of 2024, data will be collected during two timepoints (baseline and follow-up) when wanted variables for this study are routinely measured at the units.

* The Global Leadership Initiative on Malnutrition (GLIM) criteria to diagnose malnutrition in adults

Conditions

  • Malnutrition

Sponsors & Collaborators

  • Uppsala University Hospital

    collaborator OTHER

  • Umeå University

    lead OTHER

Principal Investigators

  • Sandra Einarsson, PhD · Umeå University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-21
Primary Completion
2026-06-30
Completion
2027-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06580093 on ClinicalTrials.gov